Hirsutism cost-effectiveness of therapy: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hirsutism}} | {{Hirsutism}} | ||
{{CMG}} {{AE}}{{RHN}} | {{CMG}}: {{AE}}; {{RHN}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 17:46, 22 September 2017
|
Hirsutism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Hirsutism cost-effectiveness of therapy On the Web |
|
Directions to Hospitals Treating Hirsutism cost-effectiveness of therapy |
|
Risk calculators and risk factors for Hirsutism cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: ; Rasam Hajiannasab M.D.[2]
Overview
Oral contraceptives and spironolactone are cost-effective treatment options for hirsutism.
Cost-effectiveness of Therapy
Oral contraceptives, finasteride, spironolactone and cyproterone acetate are known to be effective treatments for hirsutism, specially in short term. However in long term , using spironolactone may lead to a lower Ferriman-Gallwey score comparing to other treatments. Treatment with spironolactone is also cost-effective.
In general combination of spironolactone and oral contraceptives in patients who doesn't respond to single therapy is more cost-effective comparing to other treatment combinations.[1]
References
- ↑ Lumachi F, Zulian E, Scaroni C (2004). "Cost-effective therapy in patients with idiopathic hirsutism". Expert Rev Pharmacoecon Outcomes Res. 4 (3): 297–306. doi:10.1586/14737167.4.3.297. PMID 19807312.